Literature DB >> 17218808

Codeine and cough: an ineffective gold standard.

Donald C Bolser1, Paul W Davenport.   

Abstract

PURPOSE OF REVIEW: Cough is one of the most common reasons why patients visit physicians. The opioid codeine has been a mainstay in the treatment of cough for decades and this drug is widely regarded as the 'gold standard' cough suppressant. RECENT
FINDINGS: Recent placebo-controlled studies have shown that codeine is no more effective than placebo in suppressing cough caused by either upper respiratory disorders or chronic obstructive pulmonary disease. These recent reports are not consistent with several older placebo-controlled studies that demonstrated the efficacy of codeine. The reasons for this difference are not fully understood.
SUMMARY: We propose that these differences, as well as results from animal models, can be explained by the existence of a complex hierarchical control system that regulates the expression of coughing. This system, known as a holarchy, is composed of regulatory elements known as 'holons' that interact with one another to regulate cough. Based on work in animal models, codeine is proposed to act on an intermediate order holon that may not be critical for coughing under some situations in humans. Testing of this hypothesis and further elucidation of the control system for cough will represent an important direction for future research in this area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218808      PMCID: PMC2921574          DOI: 10.1097/ACI.0b013e3280115145

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  31 in total

Review 1.  Functional organization of the central cough generation mechanism.

Authors:  Donald C Bolser; Paul W Davenport
Journal:  Pulm Pharmacol Ther       Date:  2002       Impact factor: 3.410

2.  Conditioned enhancement of cough response in awake guinea pigs.

Authors:  A Pinto; M Yanai; K Sekizawa; T Aikawa; H Sasaki
Journal:  Int Arch Allergy Immunol       Date:  1995-09       Impact factor: 2.749

Review 3.  Brainstem respiratory networks and cough.

Authors:  R Shannon; D M Baekey; K F Morris; B G Lindsey
Journal:  Pulm Pharmacol       Date:  1996 Oct-Dec

4.  Objective assessment of antitussive agents in patients with chronic cough.

Authors:  H Sevelius; J P Colmore
Journal:  J New Drugs       Date:  1966 Jul-Aug

5.  Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis.

Authors:  L Pavesi; S Subburaj; K Porter-Shaw
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

6.  The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects.

Authors:  H A Hutchings; R Eccles
Journal:  Eur Respir J       Date:  1994-04       Impact factor: 16.671

7.  Evaluation of antitussive agents in man.

Authors:  L Parvez; M Vaidya; A Sakhardande; S Subburaj; T G Rajagopalan
Journal:  Pulm Pharmacol       Date:  1996 Oct-Dec

8.  Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection.

Authors:  M S Jawad; R Eccles
Journal:  J Pharm Pharmacol       Date:  2000-09       Impact factor: 3.765

9.  Influence of central antitussive drugs on the cough motor pattern.

Authors:  D C Bolser; J A Hey; R W Chapman
Journal:  J Appl Physiol (1985)       Date:  1999-03

10.  Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections.

Authors:  H A Hutchings; R Eccles; A P Smith; M S Jawad
Journal:  Eur Respir J       Date:  1993-11       Impact factor: 16.671

View more
  20 in total

1.  Role of the dorsomedial medulla in suppression of cough by codeine in cats.

Authors:  Ivan Poliacek; Michal Simera; Marcel Veternik; Zuzana Kotmanova; Donald C Bolser; Peter Machac; Jan Jakus
Journal:  Respir Physiol Neurobiol       Date:  2017-08-01       Impact factor: 1.931

Review 2.  Treatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy--A Pro/Con Debate.

Authors:  Ronald Eccles; Ronald B Turner; Peter V Dicpinigaitis
Journal:  Lung       Date:  2015-09-29       Impact factor: 2.584

3.  Coordination of cough and swallow: a meta-behavioral response to aspiration.

Authors:  Teresa Pitts; Melanie J Rose; Ashley N Mortensen; Ivan Poliacek; Christine M Sapienza; Bruce G Lindsey; Kendall F Morris; Paul W Davenport; Donald C Bolser
Journal:  Respir Physiol Neurobiol       Date:  2013-08-30       Impact factor: 1.931

4.  Importance of placebo effect in cough clinical trials.

Authors:  Ron Eccles
Journal:  Lung       Date:  2009-09-16       Impact factor: 2.584

Review 5.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

Review 6.  A framework for understanding shared substrates of airway protection.

Authors:  Michelle Shevon Troche; Alexandra Essman Brandimore; Juliana Godoy; Karen Wheeler Hegland
Journal:  J Appl Oral Sci       Date:  2014 Jul-Aug       Impact factor: 2.698

7.  Feed-forward and reciprocal inhibition for gain and phase timing control in a computational model of repetitive cough.

Authors:  Teresa Pitts; Kendall F Morris; Lauren S Segers; Ivan Poliacek; Melanie J Rose; Bruce G Lindsey; Paul W Davenport; Dena R Howland; Donald C Bolser
Journal:  J Appl Physiol (1985)       Date:  2016-06-09

8.  Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Authors:  Robbie L McLeod; Deen B Tulshian; Donald C Bolser; Geoffrey B Varty; Marco Baptista; Xiomara Fernandez; Leonard E Parra; Jennifer C Zimmer; Christine H Erickson; Ginny D Ho; Yanlin Jia; Fay W Ng; Walter Korfmacher; Xiaoying Xu; John Veals; April Smith-Torhan; Samuel Wainhaus; Ahmad B Fawzi; Theodore M Austin; Margaret van Heek; John A Hey
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

9.  Influence of baclofen on laryngeal and spinal motor drive during cough in the anesthetized cat.

Authors:  Daniel Castillo; Teresa Pitts
Journal:  Laryngoscope       Date:  2013-05-13       Impact factor: 3.325

Review 10.  TRPV1 antagonists as potential antitussive agents.

Authors:  Robbie L McLeod; Craig C Correll; Yanlin Jia; John C Anthes
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.